300254 Shanxi C&Y Pharmaceutical Group
- 7.81
- -0.32-3.94%
Shanxi C&Y Pharmaceutical Group News
Shanxi C&Y Pharmaceutical Group: List of restricted stock incentive plan beneficiaries (as of grant date) in 2024.
Shanxi C&Y Pharmaceutical Group: Self-inspection report on the insider information and stock trading of the persons aware of the 2024 Restricted Stock Incentive Plan and incentive targets.
Shanxi C&Y Pharmaceutical Group: Legal opinion of Guohao Law Firm (Shanghai) on the grant of restricted stock incentive plan of Shanxi C&Y Pharmaceutical Group Co., Ltd. in 2024.
Shanxi C&Y Pharmaceutical Group: Announcement on Granting Restricted Stocks to Incentive Object
Shanxi C&Y Pharmaceutical Group: Supervisory Board's verification opinion on the list of restricted stock incentive plan beneficiaries (as of the grant date) for the company in 2024.
Shanxi C&Y Pharmaceutical Group: Explanation of the Board of Supervisory Committee's review opinions and disclosure on the list of incentive recipients in the Company's 2024 Restricted Stock Incentive Plan
Shanxi C&Y Pharmaceutical Group: Qianyuan Pharmaceutical 2024 Restricted Stock Incentive Plan Self-Inspection Form
Shanxi C&Y Pharmaceutical Group: Supervisory Board's Review Opinions on the Company's 2024 Restricted Stock Incentive Plan (Draft)
Shanxi C&Y Pharmaceutical Group: 2024 Restricted Stock Incentive Plan Incentive Recipients List
Shanxi C&Y Pharmaceutical Group: Summary of Qianyuan Pharmaceutical's 2024 Restricted Stock Incentive Plan (Draft)
Shanxi C&Y Pharmaceutical Group: Legal Opinion of Guohao Lawyers (Shanghai) Firm on the 2024 Restricted Stock Incentive Plan of Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi C&Y Pharmaceutical Group: Qianyuan Pharmaceutical 2024 Restricted Stock Incentive Plan (Draft)
Qianyuan Pharmaceutical: 2023 Stock Issuance Plan to Specific Targets (Revised Draft)
Qianyuan Pharmaceutical: Announcement on the 2023 Stock Issuance Plan to Specific Targets and Revision Instructions on Related Documents
Qianyuan Pharmaceutical: 2023 Stock Issuance Plan Demonstration Analysis Report to Specific Targets (Revised Draft)
Qianyuan Pharmaceutical: Issuance of Shares to Specific Targets in 2023, Diluted Immediate Returns and Remediation Measures and Related Entity Commitments (Revised Draft)
Qianyuan Pharmaceutical: An indicative announcement on the 2023 Stock Issuance Plan to Specific Targets
Qianyuan Pharmaceutical: The company issued shares to specific targets in 2023 to dilute spot returns and fill in returns measures and commitments from relevant entities
Qianyuan Pharmaceutical: Written review opinions of the company\'s board of supervisors on matters relating to the company\'s issuance of shares to specific targets
Qianyuan Pharmaceutical: Announcement on the signing of the “Jiangsu Jiayi Pharmaceutical Co., Ltd. Equity Repurchase Agreement”
Analysis
Price Target
No Data
